Modifications

== Remarque préliminaire ==

== Remarque préliminaire ==

Le Borreliose-Centrum-Augsburg / BCA-clinic a fermé ses portes en septembre 2020. Son site web n'existe plus depuis cette date. Carsten Nicolaus est allé poursuivre ses activités aux USA.<ref>https://www.infectolab-americas.com/about-us <br>Carsten Nicolaus M.D, PhD<br>CEO<br>Born in Lower Saxony, Dr. Nicolaus studied medicine in Regensburg and received his MD license to practice medicine in 1988 and then in 1989 he received his doctorate from the Technical University of Munich Rechts der Isar hospital. Opening a general medicine practice in one of Germany’s endemic Lyme hotspots, he started treating Lyme patients early on in his career. Given the rise and spread of tick-borne illnesses, he founded the Borreliose Centrum Augsburg (BCA) in 2006, which specializes in treating tick-borne diseases. In response to the difficult nature of diagnosing tick-borne diseases, he founded the BCA laboratory that provides a comprehensive tick-borne disease testing and advanced, innovative laboratory techniques to improve diagnostics and treatment. Being involved as a board member of ILADS from 2012 to 2017, he realized that tick-borne diseases are a growing problem in the US and advanced diagnostic tools were not accessible in the US. This led to the decision to start Infectolab Americas with Bernhard Ammann and make the improved lab testing available in the US.<br>[suit la présentation de ses deux associés]<br>Adresse du siège de l'antreprise: 3510 Hopkins Pl N<br>Oakdale, MN 55128 USA</ref> En conséquence, les références mentionnées sur son site web disparu sont morts. Il arrive aussi que des informations sur Nicolaus aient été retirés sur les sites de l'ILADS et de la "Charles E. Holman Foundation" (voir à [[Maladie des Morgellons]]).

Le Borreliose-Centrum-Augsburg / BCA-clinic a fermé ses portes en septembre 2020. Son site web n'existe plus depuis cette date. Carsten Nicolaus est allé poursuivre ses activités aux USA.<ref>https://www.infectolab-americas.com/about-us <br>Carsten Nicolaus M.D, PhD<br>CEO<br>Born in Lower Saxony, Dr. Nicolaus studied medicine in Regensburg and received his MD license to practice medicine in 1988 and then in 1989 he received his doctorate from the Technical University of Munich Rechts der Isar hospital. Opening a general medicine practice in one of Germany’s endemic Lyme hotspots, he started treating Lyme patients early on in his career. Given the rise and spread of tick-borne illnesses, he founded the Borreliose Centrum Augsburg (BCA) in 2006, which specializes in treating tick-borne diseases. In response to the difficult nature of diagnosing tick-borne diseases, he founded the BCA laboratory that provides a comprehensive tick-borne disease testing and advanced, innovative laboratory techniques to improve diagnostics and treatment. Being involved as a board member of ILADS from 2012 to 2017, he realized that tick-borne diseases are a growing problem in the US and advanced diagnostic tools were not accessible in the US. This led to the decision to start Infectolab Americas with Bernhard Ammann and make the improved lab testing available in the US.<br>[suit la présentation de ses deux associés]<br>Adresse du siège de l'antreprise: 3510 Hopkins Pl N<br>Oakdale, MN 55128 USA</ref> En conséquence, les références mentionnées sur son site web disparu sont morts. Il arrive aussi que des informations sur Nicolaus aient été retirés sur les sites de l'[[ILADS]] et de la "Charles E. Holman Foundation" (voir à [[Maladie des Morgellons]]).

== Propositions de traitements de la BCA-clinic ==

== Propositions de traitements de la BCA-clinic ==